VESCOVINI, Rosanna
 Distribuzione geografica
Continente #
NA - Nord America 971
EU - Europa 840
AS - Asia 478
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.308
Nazione #
US - Stati Uniti d'America 944
CN - Cina 280
SE - Svezia 209
IE - Irlanda 177
IT - Italia 149
SG - Singapore 127
DE - Germania 94
FI - Finlandia 81
TR - Turchia 56
UA - Ucraina 33
CA - Canada 20
FR - Francia 20
AT - Austria 16
BE - Belgio 15
CI - Costa d'Avorio 15
RO - Romania 13
CZ - Repubblica Ceca 10
GB - Regno Unito 10
IN - India 10
PA - Panama 6
ES - Italia 3
EU - Europa 3
IR - Iran 3
LT - Lituania 3
NL - Olanda 3
PT - Portogallo 2
BZ - Belize 1
JP - Giappone 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
RU - Federazione Russa 1
Totale 2.308
Città #
Chandler 209
Dublin 176
Singapore 105
Ashburn 70
Dearborn 61
Jacksonville 59
Parma 59
Shanghai 55
Ann Arbor 54
Beijing 46
Boardman 44
Nanjing 41
Izmir 38
New York 30
Princeton 30
Wilmington 23
Shenyang 20
Kocaeli 18
San Mateo 17
Toronto 17
Munich 16
Vienna 16
Abidjan 15
Bremen 15
Brussels 15
Kunming 15
Marseille 13
Helsinki 12
Woodbridge 11
Hebei 10
Hefei 10
Brno 9
Des Moines 9
Jinan 9
Los Angeles 9
Milan 9
Nanchang 9
Redmond 9
Düsseldorf 8
Changsha 7
Santa Clara 7
Focsani 6
Tianjin 6
Jiaxing 5
Bologna 4
Norwalk 4
Pune 4
Reggio Emilia 4
Savignano sul Rubicone 4
Ahmedabad 3
Cesena 3
Houston 3
Madrid 3
Mestre 3
Modena 3
Ningbo 3
Rockville 3
Rome 3
Seattle 3
Taizhou 3
Torino 3
Washington 3
Arcevia 2
Bilthoven 2
Buffalo 2
Cambridge 2
Dallas 2
Deiva Marina 2
Falls Church 2
Fremont 2
Fuzhou 2
Guangzhou 2
Haikou 2
London 2
Ottawa 2
Piacenza 2
Taiyuan 2
Zhengzhou 2
Abbiategrasso 1
Aquila 1
Ardabil 1
Atlanta 1
Augusta 1
Baotou 1
Belize City 1
Castelfranci 1
Charlotte 1
Chengdu 1
Cork 1
Denver 1
Fairfield 1
Frankfurt am Main 1
Genoa 1
Halifax 1
Hangzhou 1
Huizen 1
Lagos 1
Lanzhou 1
Leawood 1
Leipzig 1
Totale 1.535
Nome #
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 105
Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis 102
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 102
The dynamics of circulating T cell subsets in CMV infected and non-infected subjects. 101
Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells 100
Impact of persistent cytomegalovirus infection on dynamic changes in human immune system profile 95
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 87
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 83
Human cytomegalovirus infection in an as yet unexplored at-risk category of subjects: elderly subjects facing acute ischemic stroke 82
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 82
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 80
Human cytomegalovirus infection in an unexplored "at risk" category of subjects. 78
MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study 76
Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status 75
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 74
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 71
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 69
T-cell dynamics in aging: studies on antigen and cytokine-specific CD8+ T cell subset in humans. III Int. Conf. on basic biology and clinical impact on immunosenescence. Palermo, aprile 2002. Abs p.31 67
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 67
A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis. 66
Variability of CD8+ T Cells Subversion According to Age and Antigen-specific Responses to Cytomegalovirus in Later Life. 65
T cell dynamics in aginmg: relationship between loss of CD95- and increase of CD28- T cells, Third Eur. Congr. Geriatr., Catania 2001, Abs Book p. 118 65
Expansion of cytotoxic CD8+, CD28- cells in healthy ageing people, including centenarians. 64
Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects 62
Thrombotic thrombocytopenic purpura with severe neurologicalimpairment: remission after Rituximab. 62
HCMV infection and clinical outcomes in Stroke patients. 59
HCMV infection, inflammation and age-related diseases: a dangerous association 58
T-lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians, 56
The immune system in extreme longevity 54
Report from the Second Cytomegalovirus and Immunosenescence Workshop. 53
The impact of CD56 expression in smoldering myeloma patients on early progression 44
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 29
CD38 expression by plasma cells in extramedullary multiple myeloma 24
Totale 2.357
Categoria #
all - tutte 9.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020208 0 0 0 0 26 49 55 4 30 23 5 16
2020/2021196 11 15 6 11 26 4 13 11 39 26 20 14
2021/2022194 16 5 6 16 10 6 21 24 8 11 12 59
2022/2023781 83 96 64 48 72 81 29 46 214 13 21 14
2023/2024325 18 24 7 9 25 81 34 25 7 18 20 57
2024/2025228 21 38 47 90 32 0 0 0 0 0 0 0
Totale 2.357